pnt001
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 17, 2019 (NCT04096287)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Microtubule-associated protein tauINHIBITOR
MAPT inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04677829 | Phase 1 | Dec 31, 2020 | Department of Defense, Pinteon Therapeutics, Inc |
| NCT04096287 | Phase 1 | Sep 17, 2019 | Pinteon Therapeutics, Inc |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pinteon Therapeutics, Inc | For profit | 2 | 2 | 1 | 2019 |
| Department of Defense | Government | 1 | 0 | 1 | 2020 |
2 organizations
Page 1 / 1